ribavirin has been researched along with cysteine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kumada, H; Tsubota, A | 1 |
| Imazeki, F | 1 |
| Yamada, G | 1 |
| Bonville, CA; Domachowske, JB; Rosenberg, HF | 1 |
| De Clercq, E; Koszytkowska-Stawińska, M; Mironiuk-Puchalska, E; Naesens, L; Sas, W | 1 |
4 review(s) available for ribavirin and cysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Therapeutic strategies for hepatitis C].
Topics: Antiviral Agents; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon Type I; Interferon-alpha; Interferons; Oleanolic Acid; Pharmacogenetics; Phlebotomy; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Ursodeoxycholic Acid | 2004 |
[Alternative measures for patients with chronic hepatitis C unresponsive to interferon therapy].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Clinical Trials as Topic; Cysteine; Drug Combinations; Drug Therapy, Combination; Genotype; Glycine; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Iron, Dietary; Liver Neoplasms; Oleanolic Acid; Phlebotomy; Prognosis; Ribavirin; Time Factors | 2004 |
[Clinical aspects of type-C cirrhosis of liver--diagnosis, clinical course, treatment and prognosis].
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Cysteine; Disease Progression; Drug Combinations; Drug Therapy, Combination; Fibrosis; Glycine; Hepatitis C, Chronic; Humans; Interferons; Liver; Liver Cirrhosis; Liver Neoplasms; Oleanolic Acid; Prognosis; Ribavirin; Risk; Ursodeoxycholic Acid | 2004 |
2 other study(ies) available for ribavirin and cysteine
| Article | Year |
|---|---|
Ribavirin and cysteinyl leukotriene-1 receptor blockade as treatment for severe bronchiolitis.
Topics: Acetates; Animals; Antiviral Agents; Bronchiolitis, Viral; Cyclopropanes; Cysteine; Disease Models, Animal; Drug Therapy, Combination; Humans; Leukotriene Antagonists; Leukotrienes; Lung; Mice; Mice, Inbred C57BL; Murine pneumonia virus; Pneumovirus Infections; Quinolines; Ribavirin; Sulfides; Treatment Outcome; Virus Replication | 2006 |
Synthesis of novel aza-analogues of tiazofurin with 2-[5,5-bis(hydroxymethyl)pyrrolidin-2-yl] framework as sugar mimic.
Topics: Animals; Antiviral Agents; Aza Compounds; Carbohydrates; Chlorocebus aethiops; Cysteine; DNA Viruses; Fibroblasts; HeLa Cells; Humans; Molecular Mimicry; Pyrrolidines; Ribavirin; RNA Viruses; Vero Cells | 2012 |